It’s a non-decision with big implications. On Monday, the Supreme Court turned down an appeal by Sequenom in their patent case with Ariosa. The rebuff by the highest court kills Sequenom’s prenatal screening test patent for good.
Sequenom Patent Loss a Threat to Personalized Medicine, Says Kevin Noonan
www.mendelspod.com
Sequenom Patent Loss a Threat to Personalized Medicine, Says Kevin Noonan
Mendelspod Podcast
Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.
Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.Listen on
Substack App
RSS Feed
Appears in episode
Theral Timpson
Recent Episodes
Sequenom Patent Loss a Threat to Personalized Medicine, Says Kevin Noonan